Gemtuzumab and pyrexia 
Gemtuzumab and pyrexia Patient Reports February 13, 2012
Gemtuzumab Side Effects Report #5652886-0
Gemtuzumab side effect was reported by a Physician from BELGIUM on Feb 29, 2008. Male patient, 73 years of age, was diagnosed with leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: agranulocytosis, pyrexia. Gemtuzumab dosage: 9 MG/M^2 EVERY. During the same period patient was treated with ZANTAC, ZOVIRAX. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #4597331-1
Gemtuzumab side effect was reported by a Pharmacist from on Feb 25, 2005. Female patient, 47 years of age, was diagnosed with leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: chills, pyrexia. Gemtuzumab dosage: unknown. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #5506674-6
Gemtuzumab side effect was reported by a Health Professional from CANADA on Oct 25, 2007. Male patient, weighting 27.56 lb, was diagnosed with blast crisis in myelogenous leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: chills, infusion related reaction, pyrexia, tachycardia. Gemtuzumab dosage: unknown. During the same period patient was treated with PETHIDINE HYDROCHLORIDE, HYDROCORTISONE, ACETAMINOPHEN, DIPHENHYDRAMINE. Patient recovered.
Gemtuzumab Side Effects Report #5523658-2
Gemtuzumab side effect was reported by a Health Professional from CANADA on Nov 14, 2007. Male patient, weighting 27.56 lb, was diagnosed with blast crisis in myelogenous leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: chills, infusion related reaction, pyrexia, tachycardia. Gemtuzumab dosage: unknown. During the same period patient was treated with PETHIDINE HYDROCHLORIDE, HYDROCORTISONE, PARACETAMOL, DIPHENHYDRAMINE. Patient recovered.
Gemtuzumab Side Effects Report #4639084-4
Gemtuzumab side effect was reported by a Consumer or non-health professional from on Apr 06, 2005. Female patient, 29 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: neutropenia, pyrexia, stomatitis. Gemtuzumab dosage: 6 MG 1X PER 1 DAY; INTRAVENOUS. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #4686095-9
Gemtuzumab side effect was reported by a Consumer or non-health professional from on May 27, 2005. Female patient, 29 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: neutropenia, pyrexia, sepsis
, staphylococcal infection , stomatitis. Gemtuzumab dosage: 6 MG 1X PER 1 DAY INTRAVENOUS. Patient was hospitalized. Patient recovered.Gemtuzumab Side Effects Report #5717315-7
Gemtuzumab side effect was reported by a Health Professional from UNITED STATES on Apr 24, 2008. Male patient, 32 years of age, weighting 145.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: back pain
, heart rate increased, pain in extremity, pyrexia, respiratory rate increased. Gemtuzumab dosage: 5.25 MG ONCE ON DAY 1,4,7 IV DRIP. During the same period patient was treated with CLOFARABINE. Patient was hospitalized. Patient recovered.Gemtuzumab Side Effects Report #4867013-7
Gemtuzumab side effect was reported by a Consumer or non-health professional from FRANCE on Mar 10, 2002. Male patient, 79 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: anaemia, leukopenia, pyrexia, thrombocytopenia. Gemtuzumab dosage: 9 MG/M (2) OR 15.48 MG SINGLE DOSE INTRAVENOUS. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #4867093-9
Gemtuzumab side effect was reported by a Physician from UNITED STATES on Dec 28, 2001. Male patient, 75 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: pyrexia, vomiting. Gemtuzumab dosage: unknown. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #4596052-9
Gemtuzumab side effect was reported by a Consumer or non-health professional from on Dec 15, 2004. Female patient, 71 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: exanthem, hypotension, pyrexia. Gemtuzumab dosage: 10 MG 1X PER 1 DAY INTRAVENOUS. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, DIFLUCAN, MARCUMAR, VALTREX, VORICONAZOLE. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #4867714-0
Gemtuzumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 13, 2002. Female patient, 71 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: chest pain
, pyrexia. Gemtuzumab dosage: unknown. Patient was hospitalized. Patient recovered.Gemtuzumab Side Effects Report #4867734-6
Gemtuzumab side effect was reported by a Physician from UNITED STATES on Dec 22, 2005. Male patient, 67 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: lymphadenitis, neutropenia, pyrexia. Gemtuzumab dosage: unknown. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #4867737-1
Gemtuzumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 01, 2005. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: hypotension, pyrexia. Gemtuzumab dosage: unknown. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #4866971-4
Gemtuzumab side effect was reported by a Consumer or non-health professional from FRANCE on Mar 10, 2002. Female patient, 64 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: beta haemolytic streptococcal infection, blood culture positive, bone marrow failure, nausea
, pyrexia, sepsis , staphylococcal infection . Gemtuzumab dosage: 9 MG/M(2) INTRAVENOUS. Patient was hospitalized. Patient recovered.Gemtuzumab Side Effects Report #4867026-5
Gemtuzumab side effect was reported by a Consumer or non-health professional from FRANCE on Mar 10, 2002. Male patient, 57 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: aplasia, blast cell count increased, chills, haemoglobin decreased, leukopenia, neutrophil count decreased, neutrophil percentage decreased, pyrexia, thrombocytopenia. Gemtuzumab dosage: 9 MG/M2 INTRAVENOUS. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #4867131-3
Gemtuzumab side effect was reported by a Physician from FRANCE on Mar 10, 2002. Female patient, 56 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: chills, nausea
, pyrexia. Gemtuzumab dosage: 9 MG/M^2. Patient was hospitalized. Patient recovered.Gemtuzumab Side Effects Report #4867022-8
Gemtuzumab side effect was reported by a Consumer or non-health professional from NETHERLANDS on Mar 10, 2002. Female patient, 55 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: leukopenia, pyrexia, venoocclusive liver disease. Gemtuzumab dosage: 9 MG/M(2) INTRAVENOUS. During the same period patient was treated with DIFLUCAN, CIPROXIN, ZELITREX. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #4867724-3
Gemtuzumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 13, 2002. Male patient, 54 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: pyrexia. Gemtuzumab dosage: unknown. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #4721926-5
Gemtuzumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 08, 2005. Male patient, 53 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: axillary pain, chills, headache
, infusion related reaction, oxygen saturation decreased, pyrexia. Gemtuzumab dosage: unknown. Patient recovered.Gemtuzumab Side Effects Report #4721927-7
Gemtuzumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 07, 2005. Female patient, 53 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: blood pressure decreased, capillary leak syndrome, lower respiratory tract infection, pyrexia. Gemtuzumab dosage: unknown. Patient recovered.
Gemtuzumab Side Effects Report #4576354-2
Gemtuzumab side effect was reported by a Physician from on Jan 31, 2005. Female patient, 52 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: chills, cyanosis, infusion related reaction, pyrexia, tachycardia. Gemtuzumab dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, GEMTUZUMAB OZOGAMICIN, POLARAMINE, RED BLOOD CELLS. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #4867018-6
Gemtuzumab side effect was reported by a Consumer or non-health professional from FRANCE on Mar 10, 2002. Female patient, 47 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bone pain, chills, disseminated intravascular coagulation, pyrexia. Gemtuzumab dosage: 9 MG/M2 PER DOSE INTRAVENOUS. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #4867712-7
Gemtuzumab side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 13, 2002. Male patient, 47 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: pyrexia. Gemtuzumab dosage: unknown. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #4721976-9
Gemtuzumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on July 07, 2005. Male patient, 41 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: chills, flushing, infusion related reaction, pyrexia. Gemtuzumab dosage: unknown. Patient recovered.
Gemtuzumab Side Effects Report #4867678-X
Gemtuzumab side effect was reported by a Physician from UNITED STATES on Dec 28, 1998. Female patient, 36 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: pyrexia. Gemtuzumab dosage: unknown. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #4914117-6
Gemtuzumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 09, 2002. Female patient, 33 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutropenia, platelet count decreased, pyrexia, tooth abscess. Gemtuzumab dosage: 9 MG/^2 1X PER 1 DOS. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #4867028-9
Gemtuzumab side effect was reported by a Health Professional from FRANCE on Oct 28, 1999. Male patient, 26 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: eosinophil percentage increased, leukopenia, lymphocyte percentage increased, nausea
, neutropenia, platelet count decreased, pyrexia. Gemtuzumab dosage: 9 MG/M (2) (TOTAL DOSE: 16 MG/DOSE) INTRAVENOUS 2 DOS. During the same period patient was treated with SPORANOX, ANZEMET, PLITICAN, POLARAMINE. Patient was hospitalized. Patient recovered.Gemtuzumab Side Effects Report #5523824-6
Gemtuzumab side effect was reported by a Physician from FRANCE on Nov 20, 2007. Male patient, weighting 180.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, lung infection pseudomonal, pyrexia, tuberculosis
. Gemtuzumab dosage: SINGLE DOSE: 12.0 MG; CUMULATIVE DOSE: 24 MG. Patient was hospitalized. Patient recovered.Gemtuzumab Side Effects Report #5595061-0
Gemtuzumab side effect was reported by a Physician from FRANCE on Jan 10, 2008. Male patient, weighting 180.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, lung infection pseudomonal, pyrexia, tuberculosis
. Gemtuzumab dosage: SINGLE DOSE: 12.0 MG; CUMULATIVE DOSE: 24 MG. Patient was hospitalized. Patient recovered.Gemtuzumab Side Effects Report #5297997-7
Gemtuzumab side effect was reported by a Physician from BELGIUM on Apr 11, 2007. Male patient, 62 years of age, weighting 154.3 lb, was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, encephalopathy, hepatotoxicity, pyrexia, rectal haemorrhage. Gemtuzumab dosage: unknown. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #5853048-4
Gemtuzumab side effect was reported by a Physician from BELGIUM on Aug 11, 2008. Male patient, 62 years of age, weighting 154.3 lb, was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, encephalopathy, hepatotoxicity, pyrexia, rectal haemorrhage. Gemtuzumab dosage: unknown. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #5298828-1
Gemtuzumab side effect was reported by a Physician from ITALY on Apr 05, 2007. Female patient, weighting 202.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: blood culture positive, circulatory collapse, diarrhoea, pyrexia, shock, vomiting. Gemtuzumab dosage: unknown. During the same period patient was treated with CYTARABINE, ONDANSETRON, ACYCLOVIR, SERTRALINE, IDARUBICIN, ETOPOSIDE. Patient was hospitalized. Patient died on 03/29/2007.
Gemtuzumab Side Effects Report #5354356-6
Gemtuzumab side effect was reported by a Physician from ITALY on June 01, 2007. Female patient, weighting 202.8 lb, was diagnosed with acute myeloid leukaemia, vomiting and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: blood culture positive, circulatory collapse, diarrhoea, pyrexia, septic shock, vomiting. Gemtuzumab dosage: unknown. During the same period patient was treated with CYTARABINE, ONDANSETRON, ACYCLOVIR, SERTRALINE, IDARUBICIN, ETOPOSIDE. Patient was hospitalized. Patient died on 03/29/2007.